Barclays PLC Acquires 14,065 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Barclays PLC lifted its stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 7.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 215,424 shares of the company’s stock after purchasing an additional 14,065 shares during the period. Barclays PLC’s holdings in Cytek […]
Barclays PLC lifted its stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 7.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 215,424 shares of the company’s stock after purchasing an additional 14,065 shares during the period. Barclays PLC’s holdings in Cytek […]
